BRIEF-Aspargo Labs Files Prospectus Relates To Registration Of Resale Of Up To 176.99 Mln Shares Of Common Stock By Co's Stockholders-March 2024-www.financetom.com

BRIEF-Aspargo Labs Files Prospectus Relates To Registration Of Resale Of Up To 176.99 Mln Shares Of Common Stock By Co's Stockholders

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Aspargo Labs Files Prospectus Relates To Registration Of Resale Of Up To 176.99 Mln Shares Of Common Stock By Co's Stockholders

Jan 10, 2025 3:51 AM

Jan 10 (Reuters) -

* ASPARGO LABS INC FILES PROSPECTUS RELATES TO REGISTRATION

RESALE OF UP TO 176.99 MILLION SHARES OF COMMON STOCK BY CO'S

STOCKHOLDERS

* ASPARGO LABS INC - TO LIST COMMON STOCK ON NYSE UNDER

SYMBOL

'AAGO'

* ASPARGO LABS INC - UNLIKE IPO, RESALE BY REGISTERED

STOCKHOLDERS

IS NOT BEING UNDERWRITTEN BY ANY INVESTMENT BANK

* ASPARGO LABS INC - CURRENTLY, NO PUBLIC MARKET FOR CO'S

COMMON

STOCK EXISTS

Source text:

Further company coverage: [ ]

Previous page： Magnificent Seven to add more than $1 trillion in value after Trump pauses some tariffs Next page： ResMed's Fiscal Q3 Likely to Meet Consensus Estimates; Faces Supply Chain Risks, UBS Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Magnificent Seven to add more than $1 trillion in value after Trump pauses some tariffs

Apr 9, 2025

By Aditya Soni (Reuters) -The Magnificent Seven stocks were poised to gain more than $1 trillion in market value on Wednesday after U.S. President Donald Trump approved a 90-day tariff pause, easing pressure on tech giants that had tumbled in recent sessions. Shares of the companies, which include AI chip giant Nvidia ( NVDA ), Apple, Tesla and Microsoft, were...

ResMed's Fiscal Q3 Likely to Meet Consensus Estimates; Faces Supply Chain Risks, UBS Says

Apr 9, 2025

02:45 PM EDT, 04/09/2025 (MT Newswires) -- ResMed's ( RMD ) fiscal Q3 is likely to meet consensus estimates, but the company is facing potential supply chain disruption risks due to US tariffs, UBS said in a Wednesday note. UBS estimates fiscal Q3 revenue of $1.28 billion and a core gross margin of roughly 60%, both in line with Visible...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Anixa Biosciences Shares Rise After Notice of Patent Allowance for Breast Cancer Vaccine

Apr 9, 2025

02:46 PM EDT, 04/09/2025 (MT Newswires) -- Anixa Biosciences ( ANIX ) shares were up over 10% in recent Wednesday trading after the company said it received a notice of allowance from the US Patent and Trademark Office for its breast cancer vaccine technology. The patent, licensed exclusively from Cleveland Clinic, broadens the scope of immunogenic compositions in the vaccine....